interesting, page-3

So there are holders out there! I was beginning to think I was the only one. This is an investor stock - daytraders or short termers are always getting burned on it - and ruining it for longer termers. Mind you - daytraders this time may get a windfall if funds provide the exit bid after the inclusion in the ASX300. I'd be careful on assuming the funds jump all over it - it is such a small weighting they can easily ignore it - but if it does rally it becomes a self perpetuating thing where the weighting increases as the price increases forcing them not to ignore it for too long.

Either way this is a great bet. Underlying company is worth 30-35c and Thrombowview is worth $1-$2 per share and is almost through the safety trials. In chatting with a doctor he said the safety trials are the key - the technology already works - it's more a question of side effects and if they are minor it likely they will sail through the rest of the process.

This is a stock you need to be able to hold till late 2005 I believe before you will get the best return - I believe between 200-500% or about half that on a p.a. basis.